Literature DB >> 8551799

Beta-tubulin and P-glycoprotein: major determinants of vincristine accumulation in B-CLL cells.

A Reichle1, H Diddens, F Altmayr, J Rastetter, R Andreesen.   

Abstract

Vincristine (VCR) accumulation in chronic lymphatic leukemia of B-cell origin (B-CLL) has recently been shown not to be inversely correlated to P-glycoprotein (PGP) levels. Therefore, we studied, in addition to PGP expression and accumulation of VCR, the cellular beta-tubulin content in quiescent and rhIL-2 activated B-CLL cells. VCR mediates cytotoxicity by binding to tubulin. Constitutive beta-tubulin levels in B-CLL cells varied considerably. Upon activation with rhIL-2, beta-tubulin expression increased significantly. Therefore, tubulin levels could be correlated over a wide range to VCR accumulation. When the PGP-mediated drug efflux was blocked by verapamil (VRP), tubulin levels correlated linearly to VCR accumulation. All B-CLL cases expressed PGP at different levels. There was no linear correlation between PGP expression and VCR accumulation. A modulation factor m was defined as a quotient of VCR accumulation in the presence and absence of VRP to define the extent by which VRP inhibited a steady-state accumulation of VCR. The factor allowed discrimination between B-CLLs expressing low versus high PGP, irrespective of the levels of tubulin. However, PGP and beta-tubulin levels together were predictive for VCR accumulation in steady state. There was no uniform-accumulation defect for VCR in B-cell CLL because beta-tubulin and PGP were expressed independently. Non PGP-mediated VCR transport seems to play a minor role in B-cell CLL. Leukemia-associated varying of cytoskeletal organization in B-cell CLL might be one reason for the diverse cellular responses to receptor-mediated signals.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8551799     DOI: 10.1016/0145-2126(95)00062-3

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  3 in total

1.  High expression of Bcl-2 predicts poor outcome in diffuse large B-cell lymphoma patients with low international prognostic index receiving R-CHOP chemotherapy.

Authors:  Yong Won Choi; Mi Sun Ahn; Jin-Hyuk Choi; Hyun Woo Lee; Seok Yun Kang; Seong Hyun Jeong; Joon Seong Park; Jae Ho Han; Jang-Hee Kim; Seung Soo Sheen
Journal:  Int J Hematol       Date:  2015-11-19       Impact factor: 2.490

2.  Chemomodulation of drugs involved in multidrug resistance in chronic lymphatic leukemia of the B-cell type.

Authors:  A Reichle; H Diddens; F Altmayr; J Rastetter; R Andreesen
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

3.  Physiologically Based Pharmacokinetic Models for Adults and Children Reveal a Role of Intracellular Tubulin Binding in Vincristine Disposition.

Authors:  Christine M Lee; Nicole R Zane; Gareth Veal; Dhiren R Thakker
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2019-08-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.